Literature DB >> 11758958

Bacterial meningitis in childhood at the Children's Hospital of Pittsburgh: 1988-1998.

H B Neuman1, E R Wald.   

Abstract

Bacterial meningitis is an important acute infectious disease of childhood that remains a source of substantial morbidity and mortality. The impact of the Haemophilus influenzae type b (HIB) conjugate vaccines on the epidemiology of the other bacterial causes of meningitis in childhood has received little attention. The objective of this study is to report the experience at a tertiary-care children's hospital with the occurrence of bacterial meningitis before and after the licensure of the HIB conjugate vaccine. With use of International Classification of Diseases diagnostic codes for bacterial meningitis, a list of all children admitted to Children's Hospital of Pittsburgh with a primary or secondary diagnosis of meningitis due to H. influenzae, Streptococcus pneumoniae, and Neisseria meningitidis from January 1, 1988, to December 31, 1998, was constructed. Medical records were examined for basic patient demographic information including age, gender, race, bacterial etiology of meningitis, receipt of vaccine for HIB, underlying conditions, and fatalities. Two hundred twenty-one cases of bacterial meningitis caused by H. influenzae, N. meningitidis, and S. pneumoniae were identified. The age of infected children ranged from 1 month to 18 years, with a mean and median age of 38.1 months and 13 months, respectively. Fifty-two percent of the children were female, 83% were Caucasian and 16% were African-American. Before the routine use of HIB conjugate vaccine, HIB was the bacterial species responsible for the greatest proportion of cases (average of 58%/year). The absolute number of cases of bacterial meningitis attributable to HIB declined after 1991 to an average of 2.5 cases/year. The number of cases of meningitis caused by S. pneumoniae and N. meningitidis have remained relatively stable between 1988 and 1998. The case fatality rates for children with meningitis caused by H. influenzae, S. pneumoniae, and N. meningitidis were 0.0%, 9.2%, and 7.5%, respectively. Most cases of meningitis due to HIB occurred in children who had not been immunized. Three children who received the polysaccharide vaccine developed meningitis due to HIB; there were no failures of the conjugate vaccine.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11758958     DOI: 10.1177/000992280104001102

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


  10 in total

1.  A population based study of the impact of corticosteroid therapy and delayed diagnosis on the outcome of childhood pneumococcal meningitis.

Authors:  P B McIntyre; C R Macintyre; R Gilmour; H Wang
Journal:  Arch Dis Child       Date:  2005-04       Impact factor: 3.791

2.  Effect of pneumococcal conjugate vaccine on pneumococcal meningitis.

Authors:  Heather E Hsu; Kathleen A Shutt; Matthew R Moore; Bernard W Beall; Nancy M Bennett; Allen S Craig; Monica M Farley; James H Jorgensen; Catherine A Lexau; Susan Petit; Arthur Reingold; William Schaffner; Ann Thomas; Cynthia G Whitney; Lee H Harrison
Journal:  N Engl J Med       Date:  2009-01-15       Impact factor: 91.245

3.  The causative organisms of bacterial meningitis in Korean children in 1996-2005.

Authors:  Hye Kyung Cho; Hyunju Lee; Jin Han Kang; Kwang Nam Kim; Dong Soo Kim; Yun Kyung Kim; Jung Soo Kim; Jong-Hyun Kim; Chang Hwi Kim; Hwang Min Kim; Su-Eun Park; Sung Hee Oh; Eun Hee Chung; Sung Ho Cha; Young Youn Choi; Jae Kyun Hur; Young Jin Hong; Hoan Jong Lee; Kyung-Hyo Kim
Journal:  J Korean Med Sci       Date:  2010-05-24       Impact factor: 2.153

4.  Surveillance of bacterial meningitis in the country of Georgia, 2006-2010.

Authors:  Maia Butsashvili; George Kandelaki; Medea Eloshvili; Rusudan Chlikadze; Paata Imnadze; Nata Avaliani
Journal:  J Community Health       Date:  2013-08

5.  Pneumococcal meningitis in the era of pneumococcal conjugate vaccine implementation.

Authors:  E Bingen; C Levy; E Varon; F de La Rocque; M Boucherat; P d'Athis; Y Aujard; R Cohen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-11-30       Impact factor: 3.267

Review 6.  A review of the impact of pneumococcal polysaccharide conjugate vaccine (7-valent) on pneumococcal meningitis.

Authors:  Myint Tin Tin Htar; Harish Madhava; Paul Balmer; Dina Christopoulou; Damianos Menegas; Eric Bonnet
Journal:  Adv Ther       Date:  2013-09-03       Impact factor: 3.845

7.  Long-term effects from bacterial meningitis in childhood and adolescence on postural control.

Authors:  Hannes Petersen; Mitesh Patel; Einar F Ingason; Einar J Einarsson; Ásgeir Haraldsson; Per-Anders Fransson
Journal:  PLoS One       Date:  2014-11-18       Impact factor: 3.240

8.  Effect of Pneumococcal Conjugate Vaccines on Pneumococcal Meningitis, England and Wales, July 1, 2000-June 30, 2016.

Authors:  Godwin Oligbu; Sarah Collins; Abdelmajid Djennad; Carmen L Sheppard; Norman K Fry; Nick J Andrews; Ray Borrow; Mary E Ramsay; Shamez N Ladhani
Journal:  Emerg Infect Dis       Date:  2019-09       Impact factor: 6.883

9.  Epidemiological profile of meningitis in Iran before pentavalent vaccine introduction.

Authors:  Zeinab Berangi; Manoochehr Karami; Younes Mohammadi; Milad Nazarzadeh; Seyed Mohsen Zahraei; Hamidreza Javidrad; Saber Heidari
Journal:  BMC Pediatr       Date:  2019-10-22       Impact factor: 2.125

10.  Incidence of bacterial meningitis (2001-2005) in Lazio, Italy: the results of a integrated surveillance system.

Authors:  Paolo Giorgi Rossi; Jessica Mantovani; Eliana Ferroni; Antonio Forcina; Elena Stanghellini; Filippo Curtale; Piero Borgia
Journal:  BMC Infect Dis       Date:  2009-02-05       Impact factor: 3.090

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.